7
Participants
Start Date
August 31, 2006
Primary Completion Date
June 30, 2008
Study Completion Date
May 31, 2009
Ranibizumab
0.3 mg/0.05 ml dose
Ranibizumab
0.5 mg/0.05 ml dose
The Wilmer Eye Institute at Johns Hopkins, Baltimore
Collaborators (1)
Genentech, Inc.
INDUSTRY
Johns Hopkins University
OTHER